Globus Medical (GMED) — Technical state
As of 2026-10-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
26.4% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip.
The moving-average stack
- vs 20-day-0.2%
- vs 50-day-5.6%
- vs 200-day-11.5%
- 52-week band26.4% off the high · +37.9% off the low
- Streak1 consecutive up session
- Stochastic%K 23.2 · %D 37.9 · down cross
Continue: the GMED chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-10-09
Quick answers
What is the current Closelooknet signal on GMED?
Resizing — 26.4% off its high — 26.4% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip. As of 2026-10-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is GMED above its 50-day and 200-day moving averages?
As of 2026-10-09, Globus Medical trades -5.6% below its 50-day and -11.5% below its 200-day average, with the 20-day -0.2% away.
How far is GMED from its 52-week high?
26.4% below the 52-week high and 37.9% above the 52-week low, as of 2026-10-09.
Related in the Closelooknet universe
same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DXCM DexCom Inc
- RACE Ferrari NV
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- TOST Toast Inc
- FSLR First Solar Inc
- REGN Regeneron Pharmaceuticals Inc
- ONON On Holding Ltd
- DB1.DE Deutsche Börse AG
- FAST Fastenal Company
- ISRG Intuitive Surgical Inc
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- CEVI.ST CellaVision ABindustry
- SYK Stryker Corporationindustry
- GKOS Glaukos Corpindustry
- PACB Pacific Biosciences of Californiaindustry
- TXG 10X Genomics Incindustry